Status | Study |
Recruiting |
Study Name: Prospective Study of a Pediatric Nifurtimox Formulation for Chagas' Disease Condition: Chagas Disease Date: 2015-12-07 Interventions: Drug: Nifurtimox (BAYA2502) |
Completed |
Study Name: Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients Condition: Chagas Disease Date: 2015-11-16 Interventions: Drug: Nifurtimox (BAYa2502) Oral Intake of 4 x 30 mg nifurtimox tablets |
Recruiting |
Study Name: CHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY) Condition: Chagas Disease Date: 2015-02-17 Interventions: Drug: Nifurtimox Full dose: 8 |
Completed |
Study Name: Etiologic Treatment With Benznidazole in Adult Patients With Chronic Chagas Disease. A Randomized Clinical Trial Condition: Chagas Disease Date: 2015-01-19 Interventions: Drug: Benznidazole Benznidazol |
Completed |
Study Name: Assessment of Speckle Tracking Strain Predictive Value for Myocardial Fibrosis in Chagas Disease Condition: Chagas Disease Date: 2014-12-18 Interventions: Other: No intervention was performed. No intervention was performed. |
Recruiting |
Study Name: Study to Evaluate Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chagas Disease Condition: Chagas Disease Trypanosomiasis, South American Date: 2014-08-20 Interventions: Drug: Fexinidazole Other Name: |
Completed |
Study Name: Study to Assess Bioequivalence of 30 and 120 mg Nifurtimox Tablets in Chronic Chagas' Patients Condition: Chagas Disease Date: 2013-08-20 Interventions: Drug: Nifurtimox (BAYa2502) (4 x 30 mg tablet) |
Completed |
Study Name: MicroRNAs as Biomarkers in Patients With Chagas Disease Condition: Chagas Disease Date: 2013-04-23 |
Completed |
Study Name: Syndecan-4 as a Biomarker in Patients With Chagas Disease Condition: Chagas Disease Date: 2013-04-18 |
Completed |
Study Name: Galectin-3 as a Biomarker in Patients With Chagas Disease Condition: Chagas Disease. Date: 2013-04-18 |